COMMUNIQUÉS West-GlobeNewswire

MediWound Reports Second Quarter 2019 Financial Results
13/08/2019
Total revenues of $20.7 million, driven primarily by the upfront payment from Vericel for NexoBrid ® license agreement BARDA committed additional $21 million to fund NexoBrid ® expanded access treatment protocol [...]
ASLAN Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Corporate Update
13/08/2019
SINGAPORE, Aug. 13, 2019 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical-stage oncology and immunology focused biopharma company, today reported financial results for the quarter ended 30 [...]
Six-month interim report (Q2) 2019
13/08/2019
Upgraded financial outlook and on track to deliver double-digit growth (unaudited) In Q2, ALK continued to deliver on its strategy, with broad-based growth across all regions and further strong performance from tablets [...]
Basilea starts phase 1/2 study with derazantinib in urothelial cancer
13/08/2019
Basel, Switzerland, August 13, 2019 – Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that it has initiated the phase 1/2 FIDES-02 study with the pan-fibroblast growth factor receptor (FGFR) kinase inhibitor [...]
Emerald Health Therapeutics’ Pure Sunfarms JV Reaches Q2 Sales of $32 Million, 78% EBITDA Margin, $0.65/Gram All-in Production Cost, and Third Consecutive Quarter of Profitability
13/08/2019
Emerald Health Therapeutics to report second quarter 2019 financial results on August 28th and hold conference call August 29th VICTORIA, British Columbia, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, [...]
Adamas Announces New Employment Inducement Grant
12/08/2019
EMERYVILLE, Calif., Aug. 12, 2019 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company’s board of directors granted three new employees the [...]
MediPharm Labs Reports Strong, Profitable Second Quarter Results
12/08/2019
Q2 2019 Revenue of $31.5 Million, Adjusted EBITDA of $7.7 Million, Net Income before tax of $4.1 Million TORONTO, Aug. 12, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm [...]
Novelion Therapeutics Announces Anticipated Late Filing of Quarterly Report on Form 10-Q for the Quarter Ended June 30, 2019
12/08/2019
VANCOUVER, British Columbia and CAMBRIDGE, Mass., Aug. 12, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals [...]
Molecular Templates, Inc. Reports Second Quarter 2019 Financial Results
12/08/2019
AUSTIN, Texas, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular,” “Molecular Templates” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and [...]
Equillium Reports Second Quarter 2019 Financial Results and Recent Highlights
12/08/2019
Initiated Phase 1b EQUIP proof-of-concept trial evaluating itolizumab (EQ001) for the treatment of uncontrolled asthma Investigational New Drug (IND) application accepted by FDA for itolizumab for the treatment of lupus [...]
Eyenovia Reports Second Quarter 2019 Financial Results
12/08/2019
NEW YORK, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print [...]
Tetra Bio-Pharma Engages LifeSci Advisors and LifeSci Public Relations as Strategic Partners
12/08/2019
Integrated Corporate Communications, Public Relations and Investor Relations Program to Focus on Elevating Company’s Visibility Ahead of Multiple Key Milestones ORLEANS, Ontario, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Tetra [...]
Unum Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Updates
12/08/2019
- Updated results from Phase 1 trial with ACTR707 in combination with rituximab in adults with relapsed/refractory non-Hodgkin lymphoma confirms the clinical activity achieved in previous cohorts with no adverse events [...]
Mesa Laboratories, Inc. Announces Closing of Public Offerings of Common Stock and Convertible Senior Notes, Including Full Exercise of Underwriters’ Options
12/08/2019
Source: Mesa Laboratories, Inc. – August 12, 2019 4:05 PM ET Lakewood, Colo., Aug. 12, 2019 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa”) today announced the closing of its previously announced [...]
Yield10 Bioscience Announces Second Quarter 2019 Financial Results
12/08/2019
WOBURN, Mass., Aug. 12, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN), an agricultural bioscience company which uses its “Trait Factory” to develop high value seed traits for the agriculture and food [...]
electroCore Announces Distribution Agreement with Doctor’s Medical LLC to Expand Patient Access to gammaCore
12/08/2019
BASKING RIDGE, N.J., Aug. 12, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the company has entered into an exclusive contract with Doctor’ [...]
Kura Oncology Announces Appointment of Kathleen Ford as Chief Operating Officer
12/08/2019
Appointment enhances leadership team with focus on strategic planning and operational execution SAN DIEGO, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company [...]
Trevi Therapeutics Announces Second Quarter 2019 Financial Results and Recent Business Developments
12/08/2019
Advancement of Nalbuphine ER Through Clinical Development in Multiple Indications NEW HAVEN, Conn., Aug. 12, 2019 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company [...]
Dynavax Announces Andrew Hack, M.D., Ph.D., Has Joined Board of Directors
12/08/2019
Bain Capital Life Sciences Managing Director brings extensive capital markets and diverse life sciences industry experience EMERYVILLE, Calif., Aug. 12, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ [...]

Pages